VirologyImpact of IFNL4-∆G genotype on sustained virologic response in hepatitis C genotype 1 patients treated with direct-acting antivirals
Section snippets
Acknowledgements/COI
Funding: This work was supported by intramural funds from the Department of Veterans Affairs and the Intramural Research Program of the National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict/Competing Interest Statement: None of the authors report any conflict of interest with the work presented in this manuscript.
References (13)
- et al.
Clinical Case Registries: simultaneous local and national disease registries for population quality management
J Am Med Inform Assoc
(2009) - et al.
The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection
Indian J Med Microbiol
(2017) - et al.
Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis
Int J Infect Dis
(2016) - et al.
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
J Hepatol
(2015) - et al.
The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection
Infect Genet Evol
(2017) - et al.
Association of the IFNL4-DeltaG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
J Infect Dis
(2014)
There are more references available in the full text version of this article.
Cited by (3)
The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities
2020, Expert Review of Precision Medicine and Drug DevelopmentWhat Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
2019, Journal of Interferon and Cytokine ResearchImpact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients
2019, Journal of Interferon and Cytokine Research
Published by Elsevier Inc.